Vaxfab Enterprises has issued a clarification regarding its recent warrant conversion, correcting the total number of equity shares allotted from the previously announced figure. The company's board meeting held on March 17, 2026, approved the allotment of equity shares through warrant conversion at Rs. 21.02 per share, but a typographical error in the initial disclosure required correction.

Corrected Allotment Details

The company clarified that the correct number of equity shares allotted pursuant to warrant conversion is 27,33,902 shares instead of the previously stated 27,33,903 shares. This correction was necessitated due to an inadvertent typographical/clerical error in the original disclosure.

Regulatory Compliance and Clarification

The clarification was issued on April 14, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Director Nishant Gandhi (DIN: 09250907) signed the clarification notice, which was communicated to both BSE Limited and The Calcutta Stock Exchange Limited.

The company confirmed that except for the correction in the number of shares, all other particulars, terms and conditions of the allotment remain unchanged from the original board resolution.

Corporate Structure Impact

The warrant conversion represents a significant capital expansion for the Gujarat-based company. Each warrant carried conversion rights at Rs. 21.02 per share, and the newly allotted shares rank pari-passu with existing equity shares, providing equal rights and privileges to the warrant holders.

Vaxfab Enterprises, incorporated in 1983 with CIN L51100GJ1983PLC093146, has its registered office at Scarlet Gateway, Prahladnagar Corporate Road, Ahmedabad. The company maintains transparency in its disclosure practices by promptly correcting any inadvertent errors in regulatory filings.

Vaxfab enterprises Limited has submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The filing, dated April 14, 2026, was submitted to BSE Limited and The Calcutta Stock Exchange Limited as part of the company's regulatory compliance obligations.

Regulatory Compliance Details

The certificate was submitted under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This regulation requires companies to report on dematerialization activities during each quarter.

Certificate Confirmation

Skyline Financial Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the confirmation certificate on April 1, 2026. The certificate specifically states that no physical share certificates were received for dematerialization of equity shares during the quarter ended March 31, 2026.

The certificate was signed by Parveen Sharma, Authorised Signatory of Skyline Financial Services Private Limited, and submitted to the company for onward transmission to the stock exchanges.

Company Information

Vaxfab Enterprises Limited operates under CIN L52291GJ1983PLC093146 with its registered office located at Office 304, 305, Scarlet Gateway, B/H Ashwaraj Bunglows, Prahladnagar Corporate Road, Manekbag, Ahmedabad, Gujarat. The company is listed on BSE Limited and The Calcutta Stock Exchange Limited with script code 015064 and security code 542803.

Filing Authorization

The regulatory filing was authorized by Nishant Gandhi, Director of Vaxfab Enterprises Limited (DIN: 09250907), who digitally signed the submission on April 14, 2026. The filing confirms the company's adherence to SEBI's quarterly reporting requirements for depositories and participants.